We tested whether the imputed gene expression-breast cancer associations differed by subtype using GWAS summary statistics from a case-only analysis, which specifically compared ER+ with ER− breast cancer patients (see Section 2 for details), scanning through 901 eligible genes. This evidence concerns the gene ESR1 and breast carcinoma.